9 Studies Behind Every Biological Safety Case

A device that never fails mechanically or chemically can still fail a patient biologically — the body’s response is its own test category.

Biocompatibility testing is where medical device testing for medical devices stops asking “what is this material” and starts asking “what does the body do when it meets this material.” It’s the category of evaluation that regulators weight most heavily, because it directly predicts patient risk rather than inferring it from material specification. Our testing service at the Oragadam laboratory covers nine distinct studies, each addressing a different biological interaction a device could trigger — from a single cell in a dish to a full systemic response in a living model.

Every study in our testing panel is structured around the ISO 10993 series, the internationally recognized framework for biological evaluation of medical devices. Cytotoxicity testing is usually the starting point — a cell-culture based screen that flags whether a material releases anything toxic to living cells before more complex studies are considered. Skin sensitization and irritation testing follow the same logic for surface and mucosal contact, identifying whether a material provokes an allergic or irritant response. Genotoxicity testing looks deeper still, screening for material effects on genetic material itself — a mandatory checkpoint for almost any device with sustained tissue contact.

For devices with blood contact, hemocompatibility becomes central to the evaluation — testing how a material interacts with blood components, since even minor incompatibility can trigger clotting or hemolysis in a way that other biocompatibility studies won’t catch. Pyrogenicity testing addresses a related but distinct risk: whether a device or its extract could induce a fever response once introduced into the body, a study that carries particular weight for any device with direct or indirect blood or cerebrospinal fluid contact. Systemic toxicity testing extends the risk assessment beyond the local contact site, evaluating whether a material or its extractables could produce toxic effects elsewhere in the body once absorbed. Implantation and subacute/chronic toxicity testing complete the panel for devices with prolonged tissue contact, assessing local tissue response over an extended implantation period alongside toxicity effects that only emerge with repeated or long-term exposure — exactly the kind of finding a short-duration study would miss entirely.

Together, these nine studies build the evidence base your biological evaluation report depends on. A manufacturer doesn’t need every study for every device — the right combination depends on contact duration, contact type, and device classification — and our team can help you scope exactly which studies your device actually requires under ISO 10993-1’s evaluation framework, as part of our broader medical device testing capabilities, rather than defaulting to a full panel by default.

Kiyo R&D Lab – Oragadam

Our biocompatibility testing lab is based at No.13, Srinivasa Perumal Street, Panapakkam, Serapanacheri, Greater Chennai, Tamil Nadu 601301.

Get Your Biological Evaluation File Started

Talk to our Oragadam lab team about biological safety testing for your device.

Request Biocompatibility Testing

Fill in your details below and our team will get back to you shortly.